Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuhiro Koh

Showing results (81-90 of 144) with videos related to

Pageof 15
Sort By:
Antimicrobial Agents and Chemotherapy|June 6, 2007
Activity against human immunodeficiency virus type 1, intracellular metabolism, and effects on human DNA polymerases of 4'-ethynyl-2-fluoro-2'-deoxyadenosineHirotomo Nakata, Masayuki Amano, Yasuhiro Koh, et al.
Cancer Research|December 18, 2004
Conditional overexpression of active transforming growth factor beta1 in vivo accelerates metastases of transgenic mammary tumorsRebecca S Muraoka-Cook, Hirokazu Kurokawa, Yasuhiro Koh, et al.
International Journal of Hematology|December 2, 2015
A phase I study of vorinostat combined with bortezomib in Japanese patients with relapsed or refractory multiple myelomaYoshiaki Ogawa, Michinori Ogura, Kensei Tobinai, et al.
Journal of Medicinal Chemistry|May 29, 2009
Design of HIV-1 protease inhibitors with pyrrolidinones and oxazolidinones as novel P1'-ligands to enhance backbone-binding interactions with protease: synthesis, biological evaluation, and protein-ligand X-ray studiesArun K Ghosh, Sofiya Leshchenko-Yashchuk, David D Anderson, et al.
Plos One|June 23, 2017
Development of an automated size-based filtration system for isolation of circulating tumor cells in lung cancer patientsSatomi Yagi, Yasuhiro Koh, Hiroaki Akamatsu, et al.
Analytical Chemistry|May 28, 2013
Microcavity array system for size-based enrichment of circulating tumor cells from the blood of patients with small-cell lung cancerMasahito Hosokawa, Takayuki Yoshikawa, Ryo Negishi, et al.
Cancer Treatment and Research Communications|February 13, 2026
Biomarker analyses to predict benefit of immune checkpoint inhibitors for EGFR-mutated non-small cell lung cancerKoichi Azuma, Mitsuo Osuga, Shoichi Itoh, et al.
Cancer Science|June 15, 2018
Isolation and molecular analysis of circulating tumor cells from lung cancer patients using a microfluidic chip type cell sorterMasaru Watanabe, Hirotsugu Kenmotsu, Ryo Ko, et al.
Cancers|June 2, 2021
Longitudinal Evaluation of PD-L1 Expression on Circulating Tumor Cells in Non-Small Cell Lung Cancer Patients Treated with NivolumabMio Ikeda, Yasuhiro Koh, Shunsuke Teraoka, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 24, 2013
Allosteric integrase inhibitor potency is determined through the inhibition of HIV-1 particle maturationKellie A Jurado, Hao Wang, Alison Slaughter, et al.
Pageof 15

Showing results (81-90 of 144) with videos related to

Sort By:
Pageof 15
Antimicrobial Agents and Chemotherapy|June 6, 2007
Activity against human immunodeficiency virus type 1, intracellular metabolism, and effects on human DNA polymerases of 4'-ethynyl-2-fluoro-2'-deoxyadenosineHirotomo Nakata, Masayuki Amano, Yasuhiro Koh, et al.
Cancer Research|December 18, 2004
Conditional overexpression of active transforming growth factor beta1 in vivo accelerates metastases of transgenic mammary tumorsRebecca S Muraoka-Cook, Hirokazu Kurokawa, Yasuhiro Koh, et al.
International Journal of Hematology|December 2, 2015
A phase I study of vorinostat combined with bortezomib in Japanese patients with relapsed or refractory multiple myelomaYoshiaki Ogawa, Michinori Ogura, Kensei Tobinai, et al.
Journal of Medicinal Chemistry|May 29, 2009
Design of HIV-1 protease inhibitors with pyrrolidinones and oxazolidinones as novel P1'-ligands to enhance backbone-binding interactions with protease: synthesis, biological evaluation, and protein-ligand X-ray studiesArun K Ghosh, Sofiya Leshchenko-Yashchuk, David D Anderson, et al.
Plos One|June 23, 2017
Development of an automated size-based filtration system for isolation of circulating tumor cells in lung cancer patientsSatomi Yagi, Yasuhiro Koh, Hiroaki Akamatsu, et al.
Analytical Chemistry|May 28, 2013
Microcavity array system for size-based enrichment of circulating tumor cells from the blood of patients with small-cell lung cancerMasahito Hosokawa, Takayuki Yoshikawa, Ryo Negishi, et al.
Cancer Treatment and Research Communications|February 13, 2026
Biomarker analyses to predict benefit of immune checkpoint inhibitors for EGFR-mutated non-small cell lung cancerKoichi Azuma, Mitsuo Osuga, Shoichi Itoh, et al.
Cancer Science|June 15, 2018
Isolation and molecular analysis of circulating tumor cells from lung cancer patients using a microfluidic chip type cell sorterMasaru Watanabe, Hirotsugu Kenmotsu, Ryo Ko, et al.
Cancers|June 2, 2021
Longitudinal Evaluation of PD-L1 Expression on Circulating Tumor Cells in Non-Small Cell Lung Cancer Patients Treated with NivolumabMio Ikeda, Yasuhiro Koh, Shunsuke Teraoka, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 24, 2013
Allosteric integrase inhibitor potency is determined through the inhibition of HIV-1 particle maturationKellie A Jurado, Hao Wang, Alison Slaughter, et al.
Pageof 15